Immuron Ltd vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $9 M for Immuron Ltd, 57 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 6, 2026 for Regenxbio Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025.
- Both made a net loss: $3 M for Immuron Ltd and $194 M for Regenxbio Inc.
- Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -113.8% for Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +47.0% for Immuron Ltd.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Immuron Ltd IMRN · #26,015 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇦🇺 Australia | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $9 M | $513 M |
| Revenue | $5 M | $170 M |
| Net income | $-3 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | 1.9× | 3.3× |
| Price to book | 1.7× | 5.0× |
| Free cash flow yield | -42.8% | -24.6%▲ best |
| Profitability | ||
| Gross margin | 65.5% | — |
| Operating margin | -73.3%▲ best | -94.6% |
| Net margin | -71.6%▲ best | -113.8% |
| Return on equity | -49.2%▲ best | -107.0% |
| Growth | ||
| Revenue growth | 47.0% | 104.5%▲ best |
| Revenue growth, 3 years a year | 103.5%▲ best | 14.8% |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Immuron Ltd or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $9 M for Immuron Ltd, 57 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 6, 2026 for Regenxbio Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Immuron Ltd or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025. Both made a net loss: $3 M for Immuron Ltd and $194 M for Regenxbio Inc.
Which is more profitable, Immuron Ltd or Regenxbio Inc.?
Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -113.8% for Regenxbio Inc.
Which is growing faster, Immuron Ltd or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +47.0% for Immuron Ltd.
Which is financially stronger, Immuron Ltd or Regenxbio Inc.?
Both are in the distress zone of the Altman Z-score.
More about Immuron Ltd
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.